385
Design Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
335
FY23:
285
FY24:
248
FY25:
224
(positive)
Change from FY21 to FY25
millions USD
FY21:
5.12
FY22:
6.02
FY23:
5.06
FY24:
4.05
FY25:
2.42
Total assets
Change from FY21 to FY25
millions USD
FY21:
391
FY22:
341
FY23:
290
FY24:
252
FY25:
226
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
5.28
FY22:
10.8
FY23:
9.62
FY24:
8.46
FY25:
13.1
(negative)
Change from FY21 to FY25
millions USD
FY21:
3.14
FY22:
3.05
FY23:
2.33
FY24:
1.53
FY25:
0.65
(positive)
Change from FY21 to FY25
millions USD
FY21:
382
FY22:
327
FY23:
278
FY24:
242
FY25:
213
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
391
FY22:
341
FY23:
290
FY24:
252
FY25:
226
All amounts in millions USD